Results 101 to 110 of about 12,144 (189)
[Platelet-to-lymphocyte ratio as a biomarker for predicting coronary artery lesions in Chinese children with Kawasaki disease: a Meta analysis]. [PDF]
Zhongguo Dang Dai Er Ke Za Zhi, 2023 Li YY +4 more
europepmc +1 more source
Zhongguo shiyan zhenduanxue, 2006 目的探讨冠状动脉球囊扩张后腔内β-照射对MMP2的表达。材料与方法应用酶谱检测对照组和照射组冠状动脉局部组织中MMP2水平。用计算机辅助组织形态学测量仪进行测量。结果照射组冠状动脉LAD和LCX局部组织中MMP2的水平较对照组冠状动脉LAD和LCX下降30%。照射组血管腔面积为LAD3.98±0.79mm2和LCX4.108±0.59mm2,对照组则分别为LAD2.54±0.61mm2和LCX3.01±0.55mm2 ...
崔建华, 孟晓萍, 王智慧, 孟君
doaj
Changes of plasma Rap1A levels in patients with in-stent restenosis after percutaneous coronary intervention and the underlying mechanisms. [PDF]
Zhong Nan Da Xue Xue Bao Yi Xue Ban, 2023 Gao H +5 more
europepmc +1 more source
Zhongguo shiyan zhenduanxue, 2015 急性冠状动脉综合征（ACS）再灌注心肌治疗有效治疗方法为经皮冠状动脉介入治疗（PCI）,患者术后易出现无复流现象[1],其发生率5%-50%,患者心外膜冠状动脉灌注良好,心肌灌注不良,存在早期梗死后并发症风险[2]。目前对微循环无复流防治缺乏有效治疗药物,法舒地尔为临床应用的Rho激酶抑制剂,研究证实对包括冠状动脉痉挛、冠脉再通手术后的再狭窄、PCI术中发生无复流均具有很好的治疗作用和安全性[3,4 ...
鲁硕 +6 more
doaj
[Research progress on image-based calculation of coronary artery fractional flow reserve]. [PDF]
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, 2023 Sun Z, Jiao W.
europepmc +1 more source
[Association of liver damage with coronary artery lesion and no response to intravenous immunoglobulin in the acute stage of Kawasaki disease]. [PDF]
Zhongguo Dang Dai Er Ke Za Zhi, 2022 Hu HM, Chen XZ, Zhang YL, DU ZD.
europepmc +1 more source
Zhongguo shiyan zhenduanxue, 2015 冠心病是临床上所称的冠状动脉粥样硬化性心脏病,是由于冠状动脉血管出现了动脉粥样硬化病变而导致的血管阻塞或狭窄,进一步引发心肌缺血、心脏缺氧或着坏死,最终导致心脏病,这就是"冠心病"。冠心病会导致患者出现心绞痛、心肌梗死和心肌缺血等临床症状,严重的还会出现猝死,因此 ...
于华, 梁伟, 张官鹏
doaj